Navigation Links
Diamyd Updates Gene Therapy Program and Outlines Plans for Phase I Clinical Trial for Treatment of Cancer Pain
Date:8/27/2007

the safety of NP2. In total 12 patients who suffer from severe cancer-related pain are planned to be enrolled.

"We are very pleased with the progress of the NTDDS program in Pittsburgh since acquiring Nurel Therapeutics 18 months ago," said Anders Essen-Moller, CEO of Diamyd Medical. "Not only may the NP2 project in itself result in a major therapeutic, but shareholder value is also built with the establishment of a broad platform technology that should yield numerous product candidates for which collaborations with third parties will be sought. In addition, our Diamyd Inc. lab facilities and expertise in manufacturing and preclinical areas have been fully used to move the company's lead product, the GAD-based diabetes vaccine Diamyd(R), towards Phase III trials later this year."

About Diamyd's NTDDS Technology for Treatment of Pain

Diamyd Medical owns the exclusive worldwide license rights to a portfolio of patents for the Nerve Targeting Drug Delivery System (NTDDS). This system is based on a replication incompetent viral delivery system that can express numerous therapeutic genes. The NTDDS has a natural affinity for nerve cells. Diamyd's initial NTDDS projects are focused upon peripheral and central nervous system applications. To that end, Diamyd seeks to combine the natural biology of the NTDDS (local nerve targeting) with therapeutic agents that are naturally found in the body and have a known therapeutic effect (e.g., GAD or enkephalin for treatment of pain, and neurotrophic factors for nerve damage). Thus, Diamyd believes that NTDDS proposes a new and broad class of nervous system disease therapies.

Pain is transmitted through a series of neurons that run from the skin to the brain. Pain signaling can be inhibited in several ways using the synapse between the peripheral and central nervous systems. This synapse provides input from the skin or organs as the first order neuron. The output from this synapse, the second order neuron, is
'/>"/>

SOURCE Diamyd Medical AB
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Revolutionary Immunologic Data Explains Function of Diamyd Diabetes Vaccine
2. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
3. Avalon Updates the AVN944 Phase I Hematologic Malignancies Trial
4. Medtronic Updates Long-Term ENDEAVOR I-II Clinical Data Showing Sustained Safety and Significant Reductions in Repeat Procedures
5. NCCN Updates Esophageal and Gastric Cancer Guidelines
6. Isis Pharmaceuticals Updates Its Positive Phase 2 Data for ISIS 301012 in Familial Hypercholesterolemia Patients
7. Gene Chips to Detect CYP Variations: A New Step Toward Customized Medical Therapy.
8. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
9. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
10. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
11. YM BioSciences Announces Preclinical Data Confirming Nimotuzumab Binds to the EGF Receptor and Potentiates Radiotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/19/2014)... and LYON, France , Dec. ... LLY ) and Adocia (Euronext Paris: FR0011184241 – ... developing an ultra-rapid insulin, known as BioChaperone Lispro, for ... diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® technology ... Lilly and Adocia will develop BioChaperone Lispro with the ...
(Date:12/17/2014)... Revenue and earnings above the previous year - ... In the past 2013/14 fiscal year (ended 30 September ... 4.287 billion (last year: EUR 4.190 billion) despite unfavorable currency ... million. "Overall, 2013/14 was a successful fiscal year for the ... CEO of Carl Zeiss AG. "Thanks to our broad portfolio ...
(Date:12/17/2014)... 17, 2014  Beamz Interactive, Inc. (OTCQB: BZIC), ... today announced that it has signed an agreement ... supplier of innovative prosthetic, orthotic and assistive technology ... the agreement, RSL Steeper will promote and supply ... for use within UK residential care facilities through ...
Breaking Medicine Technology:Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3ZEISS Asserts its Position in Difficult Environment 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 2Beamz Interactive, Inc. Signs UK Distribution Agreement with RSL Steeper Limited 3
... N.J., March 3, 2011 ConvaTec Healthcare, a world-leading ... community and hospital care, today announced that, recognizing favorable ... option to refinance all or a portion of its ... 22, 2010. While the year-end audit ...
... A new report released by the UNT Health ... East Texas are breathing a little easier due in part ... center,s Center for Professional and Continuing Education regarding ... (COPD).  The report shows that the educational program contributed ...
Cached Medicine Technology:ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 2ConvaTec Healthcare Announces Plans to Refinance Secured Term Loans 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 2Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 3Educational Efforts Reduce COPD Costs by $3.4 Million in East Texas Study 4
(Date:12/21/2014)... CannabisClassifieds.com celebrates marijuana’s new legal place at the table ... kind, the site has provided its faithful users with everything ... It uniquely combines the benefits of platforms like Craigslist, ... the masses. Assuring the potent herb’s followers it’s well ... approval. , Shane Chattin, Owner of Cannabis Classifieds ...
(Date:12/20/2014)... BambooIndustry.com is a leading ... has announced its bamboo flooring promotion for the ... from certified suppliers, and offers the best bamboo ... the current promotion, all customers can enjoy a ... say they know BambooIndustry.com from press releases. , ...
(Date:12/20/2014)... Dress company LunaDress has recently announced its ... Christmas Sale, offering big discounts on all of its special ... idea to own a perfect wedding gown. If you have ... then come to LunaDress. Many different wedding dress styles and ... website now and enjoy the current special offer, up to ...
(Date:12/20/2014)... December 20, 2014 Recently, VogueQueen.com, a ... VogueQueen Big Sale Online for 2015. Great ... All new and old consumers can get a discount, ... at the company’s website before January 30, 2015. , ... dresses and launched a prom dress promotion. Many customers ...
(Date:12/20/2014)... Atore, Inc, (San Francisco, CA CEO: Masashi ... focused portal on December 17th, 2014. , One ... US and Japan. , MERRY BIRTHDAY SITE : ... , MERRY BIRTHDAY MESSAGE is part of 5 future ... Features, Choose from thousands of stock photos to decorate ...
Breaking Medicine News(10 mins):Health News:CannabisClassifieds.com Maintains its “Craigslist for Cannabis” Standing with Website Re-launch 2Health News:Eco-friendy Bamboo Flooring Manufacturer BambooIndustry.com Introduces Its Bamboo Flooring Promotion for 2015 2Health News:2015 Collection of Wedding Dresses from LunaDress Online on Sale Now 2Health News:VogueQueen Big Sale Online For The Coming 2015 2Health News:Atore, Inc. Releasing the First Birthday Portal 2
... Centers to Offer Free Health Assessments, HARRISBURG, Pa., ... invited Pennsylvanians to take advantage of,free health assessments being ... Sept. 21. The free health services are available in,conjunction ... which is observed on,Sept. 18., "Nearly 800,000 Pennsylvanians ...
... NEW YORK, Sept. 17 ExL Pharma is ... cover many of the leading,issues that are impacting ... networking opportunities for Clinical, R&D,Regulatory and Medical Affairs ... medical technology companies. Listed below are details ...
... For orthopaedic implants to be successful, bone must meld ... shoulders are made of. A team of Brown University ... material that could significantly increase this success rate. , ... material around and chemically treated it and applied ...
... American College of Physicians (ACP) will publish "The Fenway ... Dr. Ken Mayer, and Hilary Goldhammer of The Fenway ... of Beth Israel Deaconess Medical Center, the textbook is ... the unique health care needs of sexual and gender ...
... to Accelerate Growth Initiatives, ROCHESTER, N.Y., Sept. ... it has completed a private placement of,$4,350,000 of ... a,group of institutional and other accredited investors. VirtualScopics,currently ... offering to expand its,sales and marketing efforts, software ...
... provides patient HIV tropism status, needed to initiate ... ... CCR5 antagonist., MALIBU, Calif., Sept. 17 Pathway ... assay (HTA) for determining the co-receptor tropism,status of HIV ...
Cached Medicine News:Health News:Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs 2Health News:Bone-growing nanomaterial could improve orthopaedic implants 2Health News:American College of Physicians publishes 'The Fenway Guide to LGBT Health' 2Health News:VirtualScopics Announces $4.35 Million Private Placement 2Health News:VirtualScopics Announces $4.35 Million Private Placement 3Health News:Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay 2Health News:Pathway Diagnostics Announces Commercial Availability of SensiTrop(TM) HIV Co-receptor Tropism Assay 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: